Clinical trial
Phase IV, Open-label, Randomized Clinical Trial on the Effect of Intravenous Iron on Quality of Life in Elderly Patients With Acute Coronary Syndrome
NCT07476859 is registered in ClinicalTrials.gov with Fundación para la Investigación del Hospital Clínico de Valencia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase IV, Open-label, Randomized Clinical Trial on the Effect of Intravenous Iron on Quality of Life in Elderly Patients With Acute Coronary Syndrome
- Lead sponsor
- Fundación para la Investigación del Hospital Clínico de Valencia
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- March 5, 2026
- Completion date
- May 31, 2028
- Enrollment
- 538 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndromes (acs), elderly (people aged 65 or more), iron deficiencies